Thievon-Wright Consulting Group Continues to Grow its Network of Clinical Trial Sites
July 13, 2015
Since its inception 17 years ago, Thievon-Wright Consulting Group and its network of sites has grown to include 14 members with 17 locations – 10 clinical pharmacology/inpatient units with 307 beds, 3 sleep centers and 17 outpatient clinics. TCWG is consistently the “go-to” network for protocol review, feedback and budgeting advice during the planning stages of CNS projects.
Over the past year, our network sites have broadened their therapeutic range to include addiction, pain management, Alzheimer’s and other neurological and movement disorders. Additionally, several sites are in the process of planning and building new units to meet industry demands, for example, to conduct complex clinical trials in the pediatric, adolescent and elderly patient populations. Many of our sites perform special procedures such as PET, MRI, EEG, PSG, actigraphy and CSF sampling. Several of our sites have access to fMRI imaging.
Sponsors and CROs consistently rely on TWCG to act as a single point of contact for the 14 members of our network to provide study feasibility, site recommendation and study support.
For a more detailed look at our sites’ most notable accomplishments and capabilities, please see our 2015 Quarterly Newsletter